ebomi
Colour theme
Sign in
Insider · CIK 0001249675

Perceptive Life Sciences Master Fund Ltd

CIK 0001249675 Name as filed on the most recent filing

Filed as Perceptive Life Sciences Master Fund Ltd (318)

817 transaction lines · from 318 filings · filed 2003-08-08 to 2025-11-13 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised. The 40 most recent are shown; the catalog may hold more for this insider.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2016-12-30 P, Open-market purchase Amicus Therapeutics IncFOLD 470,055, acquired Open Form 4 filing 0001019056-17-000004
2016-12-30 P, Open-market purchase Versartis, Inc.VSAR 1,388,846, acquired Open Form 4 filing 0001019056-17-000006
2016-12-29 P, Open-market purchase Amicus Therapeutics IncFOLD 459,917, acquired Open Form 4 filing 0001019056-16-001731
2016-12-29 P, Open-market purchase Versartis, Inc.VSAR 680,589, acquired Open Form 4 filing 0001019056-16-001733
2016-12-28 P, Open-market purchase Amicus Therapeutics IncFOLD 232,706, acquired Open Form 4 filing 0001019056-16-001731
2016-12-23 P, Open-market purchase Amicus Therapeutics IncFOLD 2 lines 410,050, acquired Open Form 4 filing 0001019056-16-001722
2016-12-22 P, Open-market purchase Amicus Therapeutics IncFOLD 854,835, acquired Open Form 4 filing 0001019056-16-001715
2016-12-06 P, Open-market purchase VBI Vaccines Inc.VBIV 10,321,063, acquired Open Form 4 filing 0001019056-17-000276
2016-12-06 P, Open-market purchase VBI Vaccines Inc.VBIV 10,321,063, acquired Open Form 4 filing 0001019056-16-001684
2016-09-29 S, Open-market sale Acelrx Pharmaceuticals IncACRX 377,117, disposed Open Form 4 filing 0001019056-16-001565
2016-09-28 S, Open-market sale Acelrx Pharmaceuticals IncACRX 472,380, disposed Open Form 4 filing 0001019056-16-001565
2016-09-15 S, Open-market sale Acelrx Pharmaceuticals IncACRX 2 lines 1,452,811, disposed Open Form 4 filing 0001019056-16-001549
2016-08-25 S, Open-market sale Amicus Therapeutics IncFOLD 7,491,000, disposed Open Form 4 filing 0001019056-16-001516
2016-05-26 P, Open-market purchase Aldeyra Therapeutics, Inc.ALDX 3,500,000, acquired Open Form 4 filing 0001019056-16-001354
2015-11-18 S, Open-market sale Acelrx Pharmaceuticals IncACRX 226,132, disposed Open Form 4 filing 0001019056-15-000923
2015-11-17 S, Open-market sale Acelrx Pharmaceuticals IncACRX 717,409, disposed Open Form 4 filing 0001019056-15-000923
2015-11-06 S, Open-market sale Acelrx Pharmaceuticals IncACRX 76,365, disposed Open Form 4 filing 0001019056-15-000884
2015-11-05 S, Open-market sale Acelrx Pharmaceuticals IncACRX 346,260, disposed Open Form 4 filing 0001019056-15-000884
2015-10-28 P, Open-market purchase Aldeyra Therapeutics, Inc.ALDX 293,150, acquired Open Form 4 filing 0001019056-15-000872
2015-10-26 P, Open-market purchase Aldeyra Therapeutics, Inc.ALDX 323,150, acquired Open Form 4 filing 0001019056-15-000844
2015-10-22 P, Open-market purchase Aldeyra Therapeutics, Inc.ALDX 116,661, acquired Open Form 4 filing 0001019056-15-000840
2015-10-20 P, Open-market purchase Aldeyra Therapeutics, Inc.ALDX 2 lines 237,193, acquired Open Form 4 filing 0001019056-15-000828
2015-10-07 P, Open-market purchase Amicus Therapeutics IncFOLD 313,500, acquired Open Form 4 filing 0001019056-15-000805
2015-10-06 P, Open-market purchase Amicus Therapeutics IncFOLD 6 lines 1,629,000, acquired Open Form 4 filing 0001019056-15-000803
2015-10-05 P, Open-market purchase Amicus Therapeutics IncFOLD 4 lines 3,402,500, acquired Open Form 4 filing 0001019056-15-000803
2015-09-09 S, Open-market sale Acelrx Pharmaceuticals IncACRX 1,294,777, disposed Open Form 4 filing 0001019056-15-000754
2015-08-14 P, Open-market purchase VBI Vaccines Inc.VBIV 1,352,000, acquired Open Form 4 filing 0001019056-15-000689
2014-11-19 P, Open-market purchase Amicus Therapeutics IncFOLD 13,650,000, acquired Open Form 4 filing 0001019056-14-001440
2014-06-30 P, Open-market purchase Amicus Therapeutics IncFOLD 2 lines 14,000,000, acquired Open Form 4 filing 0001019056-14-000885
2013-11-07 P, Open-market purchase Acelrx Pharmaceuticals IncACRX 2 lines 649,810, acquired Open Form 4 filing 0001019056-13-001256
2013-11-06 P, Open-market purchase Acelrx Pharmaceuticals IncACRX 2 lines 651,660, acquired Open Form 4 filing 0001019056-13-001256
2013-11-04 P, Open-market purchase Acelrx Pharmaceuticals IncACRX 4 lines 1,064,292, acquired Open Form 4 filing 0001019056-13-001224
2013-11-01 P, Open-market purchase Acelrx Pharmaceuticals IncACRX 1,077,033, acquired Open Form 4 filing 0001019056-13-001217

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. PERCEPTIVE LIFE SCIENCES MASTER FUND LTD, insider transactions. Retrieved 2026-08-28 from https://ebomi.com/insider/0001249675

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.